|
|
Article: The hidden prescribers: while pharmaceutical companies continue to target fewer high-prescribing physicians with less time than ever, an increasingly important segment of healthcare professionals is going largely neglected. Matthew Arnold looks at how companies can harness the growing clout of physician assistants and nurse practitioners.
- Article from:
- Medical Marketing & Media
- Article date:
- November 1, 2004
- Author:
CopyrightCOPYRIGHT 2004 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"Most companies, when they're launching a product in primary care, will advertise to PAs and NPs," says Carla Duryee, who heads marketing to midlevel practitioners for Sanofi-Aventis. "But very few will go deeper, develop thought leaders and work on long-range plans."
Midlevel practitioners, such as nurse practitioners (NPs) and physician assistants (PAs) are an oft-misunderstood and under-appreciated segment of healthcare providers. The nation's 50,000 PAs and 115,000 NPs perform a broad range of diagnostic tests, and write as many as 10 percent of all scripts in the U.S. without physician handholding. They can also receive and dispense samples in most states. ...
Related newspaper, magazine, and journal articles:
|
|
Article: PAs and NPs: How they boost practice earnings
Medical Economics;
February 16, 2007 ;
700+ words
... ... midlevel or another physician (see "NPs and PAs: A seller's market," Jan ... Next, check your state laws. NPs' and PAs' ability to prescribe varies from state to state. All NPs and PAs who prescribe controlled substances ...
|
|